MINIMAP™
Category: *Precision Health & Smart Medical
Exhibitor: WCC BIOMEDICAL CO., LTD.
Booth No: M432
Characteristic
MINIMAP™ is a proprietary device developed by WCC Biomedical to accelerate microneedle research and enable personalized treatment at the point-of-care. This innovation integrates two essential components: a hydrogel-based microneedle patch and a liquid-form active ingredient formulation. Once sprayed, the active ingredient is rapidly absorbed into the microneedle tips. Upon skin penetration, the microneedle releases the active ingredients directly into the targeted site, offering precise and efficient delivery. The simplicity and flexibility of this platform redefine how microneedles can be used in both clinical and consumer settings.
In the field of microneedle development, MINIMAP™ significantly shortens the screening and optimization process—from months to just minutes. This rapid evaluation capability allows WCC to test multiple active ingredients or formulations on-demand and iterate quickly, dramatically improving R&D speed and agility. With this breakthrough, WCC has established itself as one of the fastest developers of microneedle technology, attracting global attention and forming collaborations with partners across the pharmaceutical, biotech, and healthcare sectors.
Beyond R&D, MINIMAP™ also opens the door to personalized microneedle therapy. Its adaptable design allows for on-site customization, enabling practitioners or even consumers to create microneedle patches tailored to individual needs—whether for cosmetic rejuvenation, targeted muscle relief, or other wellness goals. By combining speed, precision, and flexibility, MINIMAP™ positions WCC at the forefront of personalized healthcare innovation at the point of care.
If you’re interested in learning how MINIMAP™ is set to transform the landscape of healthcare and the microneedle industry, we’d be delighted to discuss it with you!
Other Products
Products you may be interested in
Highest Rated Products